Pfizer Names Oncology Head Boshoff

Pfizer Names New Head Of Research And Development
Pharmaceutical giant Pfizer (PFE) has named company veteran Chris Boshoff its chief of research and development (R&D) as it looks to produce new pr
Doubling down on its strategy, Pfizer names its head of oncology as new research chief
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.
Pfizer names oncology head Chris Boshoff as R&D chief
Pfizer said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and development, as the drugmaker faces pressure from investors to produce profitable new drugs.
Pfizer Names New R&D Chief
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief scientific officer starting Jan. 1.
Pfizer promoted oncology chief Chris Boshoff to serve as CSO, R&D president
As for his soon-to-be former role, Boshoff will be succeeded by Dr. Roger Dansey, who will serve as the interim chief oncology officer. He will then hand off the role to Dr. Johanna Bendell, who will join the Pfizer team in 2025.
Pfizer elevates Chris Boshoff to top R&D role
"Dr Boshoff is the ideal leader to propel Pfizer's R&D engine forward and transform it into a world-leading organisation with a more focused strategy, driving the delivery of additional impactful breakthrough medicines with blockbuster potential," said chief executive Albert Bourla.
Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief
Chris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & development across all therapeutic area
Pfizer confirms Chris Boshoff as chief scientific officer
Pfizer (PFE) announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD,
Pfizer names insider Chris Boshoff as R&D chief
Pfizer said on Wednesday it has named company veteran Chris Boshoff, who led the drugmaker's cancer research and marketing for more than a year, as its chief of research and development. The appointment comes at a time when Pfizer is facing pressure from activist investor Starboard,
Pfizer promotes oncology chief to lead R&D as activist Starboard circles
Pfizer has promoted its oncology chief to lead all of its research and development operations, in a move that will be closely watched by the activist investor piling pressure on the struggling drugmaker.
ENDPOINTS NEWS3d
Pfiz­er taps on­col­o­gy head Boshoff as Dol­sten's chief sci­en­tif­ic of­fi­cer suc­ces­sor
Chris Boshoff will become Pfizer's chief scientific officer and R&D president on January 1, replacing Mikael Dolsten. Roger ...
Pfizer taps oncology chief to map drug-research path amid pressure from activist Starboard
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years ...
Leerink views Chris Boshoff as ‘strong choice’ for Pfizer’s CSO
Leerink notes Pfizer (PFE) announced that Chris Boshoff will become the new Chief Scientific Officer, succeeding Mikael Dolsten. The firm views ...